ArticleJournal of cardiology cases2025
Heart rate optimization to reduce tricuspid regurgitation in patients with atrial fibrillation and relative bradycardia: A case report.
Article in Journal of cardiology cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 74-year-old male with end-stage renal disease was referred for treatment of syncope and hypotension episodes during dialysis. The patient had a history of sick sinus syndrome that was managed with a VVI pacemaker, maintaining a heart rate of approximately 60 bpm, due to atrial fibrillation. Transthoracic echocardiography revealed massive tricuspid regurgitation (TR), which was identified as a significant contributor to the patient's symptoms. Surgical intervention for TR was initially considered, however echocardiographic examination with pulse Doppler of the tricuspid inflow waveform indicated that ventricular filling efficiency could be improved by increasing the pacemaker's heart rate to 80 bpm. This adjustment was validated during right heart catheterization, confirming enhanced efficiency and leading to the decision to monitor the patient's condition with the new pacemaker setting instead of proceeding with surgery. Over the next 5 months, the patient's condition significantly improved, with TR severity decreasing to moderate. This case highlights the importance of tailored heart rate optimization in managing complex heart failure, demonstrating the effectiveness of noninvasive methods in improving outcomes for patients with significant tricuspid valve disease and relative bradycardia with atrial fibrillation. Learning objective: Assessing the optimal heart rate in patients with heart failure is crucial, requiring a case-by-case evaluation rather than relying on evidence from large clinical trials. In this case, characterized by relative bradycardia with chronic atrial fibrillation and severe tricuspid valve regurgitation, we determined the optimal heart rate using the Doppler waveform of the tricuspid valve inflow to assess whether an increase in heart rate could enhance cardiac output without reducing stroke volume.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.